Karki; Shyam B.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Karki; Shyam B..The latest application filed is for "pharmaceutical bead formulations comprising dimethyl fumarate".

Company Profile

8.8.19

Karki; Shyam B. - Hillsborough NJ
Karki; Shyam B. - Lansdale PA
Karki, Shyam B - Lansdale PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Dimethyl fumarate particles and pharmaceutical compositions thereof Grant 11,291,642 - Boulas , et al. April 5, 2	2022-04-05
Pharmaceutical bead formulations comprising dimethyl fumarate Grant 11,197,842 - Karki , et al. December 14, 2	2021-12-14
Pharmaceutical Bead Formulations Comprising Dimethyl Fumarate App 20210369629 - Karki; Shyam B. ; et al.	2021-12-02
Pharmaceutical bead formulations comprising dimethyl fumarate Grant 11,033,509 - Karki , et al. June 15, 2	2021-06-15
Pharmaceutical Matrix Formulations Comprising Dimethyl Fumarate App 20190175510 - Karki; Shyam B. ; et al.	2019-06-13
Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate App 20190091146 - Zawaneh; Peter ; et al.	2019-03-28
Pharmaceutical Matrix Formulations Comprising Dimethyl Fumarate App 20190083404 - Karki; Shyam B. ; et al.	2019-03-21
Dimethyl Fumarate Particles And Pharmaceutical Compositions Thereof App 20190070143 - Boulas; Pierre ; et al.	2019-03-07
Pharmaceutical Bead Formulations Comprising Dimethyl Fumarate App 20190046456 - Karki; Shyam B. ; et al.	2019-02-14
Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate App 20190008768 - Zawaneh; Peter ; et al.	2019-01-10
Controlled release dosage form for once daily administration of dimethyl fumarate Grant 10,172,794 - Zawaneh , et al. J	2019-01-08
Pharmaceutical Bead Formulations Comprising Dimethyl Fumarate App 20180153845 - Karki; Shyam B. ; et al.	2018-06-07
Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate App 20160310419 - Zawaneh; Peter ; et al.	2016-10-27
Formulations for tyrosine kinase inhibitors App 20060093666 - Karki; Shyam B. ; et al.	2006-05-04
Process for preparing stabilized vitamin D App 20060019933 - Boardman; David ; et al.	2006-01-26
Pharmaceutical composition containing and indolopyrrolocarbazole derivative Grant 6,979,676 - Sato , et al. December 27, 2	2005-12-27
Orally active salts with tyrosine kinase activity Grant 6,960,590 - Fraley , et al. November 1, 2	2005-11-01
Solid forms of slats with tyrosine kinase activity App 20050113577 - Karki, Shyam B ; et al.	2005-05-26
Sustained release delivery of a thrombin inhibitor App 20040213850 - Dokou, Eleni ; et al.	2004-10-28
Hiv protease inhibitors supported on cation exchange resins for oral administration App 20040067216 - Karki, Shyam B.	2004-04-08
Pharmaceutical composition containing an indolopyrrolocarbazole derivative App 20040029821 - Sato, Yuichi ; et al.	2004-02-12
Active salt forms with tyrosine kinase activity App 20040023978 - Ren, Yu ; et al.	2004-02-05
Salt forms with tyrosine kinase activity App 20040023981 - Ren, Yu ; et al.	2004-02-05
Orally active salts with tyrosine kinase activity App 20040002501 - Fraley, Mark E. ; et al.	2004-01-01
Orally active salts with tyrosine kinase activity Grant 6,656,942 - Fraley , et al. December 2, 2	2003-12-02
Orally active salts with tyrosine kinase activity App 20020072526 - Fraley, Mark E. ; et al.	2002-06-13
Salt form of a conjugate useful in the treatment of prostate cancer Grant 6,355,611 - Karki , et al. March 12, 2	2002-03-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.